A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Phase of Trial: Phase I/II
Latest Information Update: 29 Oct 2014
At a glance
- Drugs Bupropion/trazodone (Primary) ; Bupropion
- Indications Decreased libido
- Focus Therapeutic Use
- Acronyms PURPLE
- 27 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Mar 2014 Results data for the phase IIa part of this trial are expected in the second quarter of 2014, according to a S1 Biopharma media release.
- 29 Jul 2013 Enrolment and dosing has been initiated in the phase IIa part of the study, and results data are expected in the first quarter of 2014, according to an S1 Biopharma media release.